Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.6000
+0.0061 (1.03%)
Aug 22, 2025, 4:00 PM - Market closed
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.32M in the quarter ending June 30, 2025, with 25.34% growth. This brings the company's revenue in the last twelve months to $9.08M, up 7.84% year-over-year. In the year 2024, Milestone Scientific had annual revenue of $8.63M, down -12.19%.
Revenue (ttm)
$9.08M
Revenue Growth
+7.84%
P/S Ratio
5.32
Revenue / Employee
$534,306
Employees
17
Market Cap
47.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.63M | -1.20M | -12.19% |
| Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
| Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
| Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
| Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MLSS News
- 10 days ago - Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 - GlobeNewsWire
- 11 days ago - Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call - GlobeNewsWire
- 18 days ago - Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing - GlobeNewsWire
- 23 days ago - Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer - GlobeNewsWire
- 5 weeks ago - Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey - GlobeNewsWire
- 3 months ago - Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors - GlobeNewsWire
- 3 months ago - Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 - GlobeNewsWire
- 5 months ago - Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey - GlobeNewsWire